Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis.

COVID-19 SARS-CoV-2 coronavirus attention cognition cognitive dysfunction executive functions neuropsychological test

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2022
Historique:
revised: 01 02 2022
received: 10 10 2021
accepted: 04 02 2022
pubmed: 18 3 2022
medline: 11 5 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

We conducted a systematic review and meta-analysis of the cognitive effects of coronavirus disease 2019 (COVID-19) in adults with no prior history of cognitive impairment. Searches in Medline/Web of Science/Embase from January 1, 2020, to December 13, 2021, were performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.  A meta-analysis of the Montreal Cognitive Assessment (MoCA) total score comparing recovered COVID-19 and healthy controls was performed. Oof 6202 articles, 27 studies with 2049 individuals were included (mean age = 56.05 years, evaluation time ranged from the acute phase to 7 months post-infection). Impairment in executive functions, attention, and memory were found in post-COVID-19 patients.  The meta-analysis was performed with a subgroup of 290 individuals and showed a difference in MoCA score between post-COVID-19 patients versus controls (mean difference = -0.94, 95% confidence interval [CI] -1.59, -0.29; P = .0049). Patients recovered from COVID-19 have lower general cognition compared to healthy controls up to 7 months post-infection.

Identifiants

pubmed: 35297561
doi: 10.1002/alz.12644
pmc: PMC9073922
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1047-1066

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 the Alzheimer's Association.

Références

Acta Neurobiol Exp (Wars). 2021;81(1):69-79
pubmed: 33949163
Brain. 2017 Aug 1;140(8):2246-2251
pubmed: 28899018
Alzheimers Dement. 2022 May;18(5):1047-1066
pubmed: 35297561
Psychiatry Clin Neurosci. 2021 Feb;75(2):66-67
pubmed: 33241874
Brain. 2021 May 7;144(4):1263-1276
pubmed: 33822001
EClinicalMedicine. 2021 Jan 07;31:100683
pubmed: 33490928
Am J Respir Crit Care Med. 2020 Jul 15;202(2):193-201
pubmed: 32078780
J Neurol Sci. 2022 Jan 15;432:120061
pubmed: 34894422
Acta Neurol Belg. 2020 Oct;120(5):1051-1060
pubmed: 32562214
Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):194-200
pubmed: 26243848
J Neurovirol. 2021 Feb;27(1):191-195
pubmed: 33528824
S Afr Med J. 2020 Nov 23;111(1):10-12
pubmed: 33403997
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):225-232
pubmed: 28111267
Brain Behav Immun. 2021 Jan;91:383-392
pubmed: 33148439
PLoS One. 2021 Feb 8;16(2):e0246590
pubmed: 33556127
BMJ Open. 2021 Oct 27;11(10):e055164
pubmed: 34706965
Clin Neuropsychol. 2021 May;35(4):799-818
pubmed: 33487098
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Eur J Neurol. 2021 Oct;28(10):3245-3253
pubmed: 33576150
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Virusdisease. 2021 Mar;32(1):146-149
pubmed: 33614860
Intensive Care Med. 2016 May;42(5):725-738
pubmed: 27025938
Arq Neuropsiquiatr. 2022 Mar;80(3):240-247
pubmed: 34816972
Brain Commun. 2020 Nov 23;2(2):fcaa205
pubmed: 33376990
Neurol Res Pract. 2021 Mar 12;3(1):17
pubmed: 33712089
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Neurol Sci. 2021 Jan 15;420:117271
pubmed: 33359928
JAMA Netw Open. 2021 Oct 1;4(10):e2130645
pubmed: 34677597
J Nucl Med. 2022 Jul;63(7):1058-1063
pubmed: 34649946
J Neurol Neurosurg Psychiatry. 2021 May;92(5):567-568
pubmed: 33219042
Brain Behav Immun Health. 2020 Dec;9:100163
pubmed: 33111132
Eur Neuropsychopharmacol. 2021 May;46:39-48
pubmed: 33823427
Neurol Sci. 2022 Jan;43(1):45-50
pubmed: 34779965
J Intern Med. 2021 Sep;290(3):621-631
pubmed: 33533521
Neurology. 2013 Aug 13;81(7):650-7
pubmed: 23873971
J Psychosom Res. 2021 Feb;141:110350
pubmed: 33401078
J Clin Neurosci. 2021 May;87:153-155
pubmed: 33863524
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):47-50
pubmed: 21808439
J Acad Consult Liaison Psychiatry. 2022 Mar-Apr;63(2):133-143
pubmed: 34793996
Arch Phys Med Rehabil. 2021 Jan;102(1):155-158
pubmed: 32991870
BMJ. 2021 Jan 22;372:n136
pubmed: 33483331
Front Neurol. 2020 Nov 05;11:574004
pubmed: 33224088
Sci Data. 2020 Oct 8;7(1):345
pubmed: 33033256
J Alzheimers Dis. 2021;80(3):1257-1267
pubmed: 33646151

Auteurs

Lucia Crivelli (L)

Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.

Katie Palmer (K)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
FINGERS Brain Health Institute, Stockholm, Sweden.

Ismael Calandri (I)

Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.

Alla Guekht (A)

Moscow Research and Clinical Center for Neuropsychiatry, Russia, and Pirogov Russian National Research University, Moscow, Russia.

Ettore Beghi (E)

Department of Neuroscience, Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

William Carroll (W)

Department of Neurology, Sir Charles Gairdner Hospital and Center for Neuromuscular and Neurological Disorders Perron Institute, Perth, Western Australia, Australia.

Jennifer Frontera (J)

Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.

David García-Azorín (D)

Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Erica Westenberg (E)

Department of Neurology, Center for Global Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Andrea Sylvia Winkler (AS)

Department of Neurology, Center for Global Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany and Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.

Francesca Mangialasche (F)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
FINGERS Brain Health Institute, Stockholm, Sweden.

Ricardo F Allegri (RF)

Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
Department of Neurosciences, Universidad de la Costa, Barranquilla, Colombia.

Miia Kivipelto (M)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
FINGERS Brain Health Institute, Stockholm, Sweden.
Medical Unit Aging, Karolinska University Hospital, Stockholm, Sweden.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, United Kingdom.
Institute of Public Health and Clinical Nutrition and Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH